Literature DB >> 29025242

The diagnosis and management of congenital and adult-onset hyperinsulinism (nesidioblastosis) - literature review.

Adam M Kowalewski, Łukasz Szylberg, Anna Kasperska, Andrzej Marszałek.   

Abstract

Congenital and adult-onset hyperinsulinism (CHI) must be taken under consideration in the differential diagnosis of hypoglycaemia symptoms with endogenous hyperinsulinism, especially in cases in which there was failure to find an insulinoma. Histological examination is necessary for a definitive diagnosis. CHI is a disorder with three histopathological variants: focal CHI, diffuse CHI, and atypical CHI. These variants are clinically indistinguishable. According to published statistics, 0.5 to 5% of nesidioblastosis cases occur in adults. Clinical manifestation ranges from mildly symptomatic up to life-threatening hypoglycaemia. Early diagnosis and treatment are important in young and very young patients because early treatment accounts for favourable mental outcomes.

Entities:  

Keywords:  adult; diagnosis; hyperinsulinism; management; nesidioblastosis; congenital

Mesh:

Year:  2017        PMID: 29025242     DOI: 10.5114/pjp.2017.69684

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  4 in total

1.  Entire FGF12 duplication by complex chromosomal rearrangements associated with West syndrome.

Authors:  Yoichiro Oda; Yuri Uchiyama; Ai Motomura; Atsushi Fujita; Yoshiteru Azuma; Yutaka Harita; Takeshi Mizuguchi; Kumiko Yanagi; Hiroko Ogata; Kenichiro Hata; Tadashi Kaname; Yoichi Matsubara; Keiko Wakui; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-07-16       Impact factor: 3.172

2.  Adult-Onset Focal Nesidioblastosis With Nodular Formation Mimicking Insulinoma.

Authors:  Shunsuke Doi; Takatsugu Yamada; Yoshinori Kito; Shinsaku Obara; Yusuke Fujii; Takao Nishimura; Tatsushi Kato; Hiroyuki Nakayama; Masahiro Tsutsumi; Ryuji Okamura
Journal:  J Endocr Soc       Date:  2021-12-11

3.  Insulin autoimmune syndrome induced by exogenous insulin injection: a four-case series.

Authors:  Yimin Shen; Xiaoxiao Song; Yuezhong Ren
Journal:  BMC Endocr Disord       Date:  2019-12-28       Impact factor: 2.763

4.  Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor-Positive Lesions.

Authors:  Marti Boss; Desiree Bos; Cathelijne Frielink; Gerwin Sandker; Patricia Bronkhorst; Sanne A M van Lith; Maarten Brom; Mijke Buitinga; Martin Gotthardt
Journal:  J Nucl Med       Date:  2020-05-08       Impact factor: 10.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.